Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2003
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003CA2469342A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/19/2003CA2467573A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003CA2460122A1 Pyrazoles-pyrimidine fungicides
06/18/2003EP1319185A1 Method for identifying compounds with anti-herpes activity
06/18/2003EP1319039A2 Pyrimidine derivatives as hardness stabilizers
06/18/2003EP1318999A1 Thiazole derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/17/2003US6579894 Bactericides, fungicides
06/17/2003US6579893 Related thiazolidinediones
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/17/2003US6579871 Methods of using novel compounds as neuro-protective agents
06/17/2003US6579718 For detecting and quantifying peptides, polypeptides and proteins; sensitive, facile and does not require use of organic solvents
06/17/2003CA2220698C N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
06/12/2003WO2003048155A1 Thrombin inhibitors
06/12/2003WO2003048140A1 Azole compound and medicinal use thereof
06/12/2003WO2003048136A1 Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048122A2 Inhibitors of cytosolic phospholipase a2
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047570A1 Benzazole derivatives for the treatment of scleroderma
06/12/2003WO2003047512A2 Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
06/12/2003WO2003047347A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
06/12/2003WO2002064094A3 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/12/2003US20030109706 Serine pretease inhibitors
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109701 Crystalline forms of meloxicam and processes for their preparation and interconversion
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109555 Targeted drug delivery using sulfonamide derivatives
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109533 New benzenesulphonamide compounds
06/12/2003US20030109530 Diabetes, insulin resistance, dyslipidemia, obesity, high blood pressure, atherosclerosis, retinopathies and neurodegenerative disorders; synthesis by reacting a biguanide with an aldehyde, semiacetal or acetal in presence of acid catalyst
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109521 Aryl substituted thiazolidinones and the use thereof
06/12/2003US20030109520 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
06/12/2003US20030108970 Generating antibodies; quantitative analysis
06/12/2003CA2469385A1 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
06/12/2003CA2469228A1 Azole compound and medicinal use thereof
06/12/2003CA2463794A1 Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
06/11/2003EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them
06/11/2003EP1318147A1 Novel pyrimidine derivative and novel pyridine derivative
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317453A1 Isoxazoles and their use as inhibitors of erk
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317445A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317432A1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003CN1423650A Method for producing heterocyclic compounds
06/11/2003CN1423648A 1-(H-1,2,4-triazol-1-yl) butan-2-ol derivatives
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/10/2003US6576662 Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them
06/10/2003US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2190130C Thiadiazoles and their use as antipicornaviral agents
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/10/2003CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments
06/05/2003WO2003045947A1 Rosiglitazone edisylates and their use as antidiabetics
06/05/2003WO2003045946A1 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
06/05/2003WO2003045945A1 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045939A1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045925A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045901A2 Guanidine derivatives
06/05/2003WO2003045386A1 Benzothiazole derivatives
06/05/2003WO2003045385A1 Benzothiazole derivatives
06/05/2003WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
1 ... 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 ... 628